Biomedical Engineering Reference
In-Depth Information
21. Bayston R, Bhundia C, Ashraf WW. 2005. Hydromer-coated catheters to prevent
shunt infection?
J Neurosurg
102 (suppl 2): 207-212.
22. Cagavi F, Akalan N, Celik H, Gur D, Guciz B. 2004. Effect of hydrophilic coating on
microorganism colonization in silicone tubing.
Acta Neurochir
(Wien) 146: 603-10.
23. Furno F, et al. 2004. Silver nanoparticles and polymeric medical devices: A new
approach to prevention of infection?
J Antimicrob. Chemother.
54: 1019-24.
24. Wang PP, Frazier J, Brem H. 2002. Local delivery to the brain.
Adv Drug Deliv.
Res.
54: 987-1013.
25. Miisra A, Ganesh S, Shalhiwala A, Shah SP. 2003. Drug delivery to the central
nervous system: A review.
J Pharm Pharmacol Sc
6: 252-273.
26. Kaur LP, Bhander R, Bhander S, Kakkar V. 2008. Potential of solid lipid nanopar-
ticles in brain targeting.
J Control Rel
127: 97-109.
27. Siwak DR, Tari AM, Lopex-Brenestein G. 2002. The potential of drug-carrying
immunoliposomes as anticancer agents.
Clin Cancer Res
8: 955-56.
28. Lown JW. 1993. Anthracycline and anthraquinone anticancer agents: Current
status and recent developments.
Pharmacol. Ther.
60 (2): 185-214.
29. Tyler B, Grossman R, Patta Y, Upadhyay U, Huey L, Azadi J, Cima MJ, Brem
H. Systemically delivered doxil increases survival in both an intracranial glio-
sarcoma model and an intracranial metastatic breast cancer model in rodents.
Poster submission: American Association of Neurological Surgeons, Annual
Meeting Spring 2011.
30. Lockman PR, Mumper RJ, Kgan MA, Allen DD. 2002. Nanoparticle technology
for drug delivery across the blood-brain barrier.
Drug Dev Ind Pharm
28: 11-13
.
31. Garcia-Garcia F, Andreiux K, Gill S, Couvereur P. 2005. Colloidal carriers and
blood-brain barrier translocation: A way to deliver drugs to the brain?
Int J
Pharm
298: 274-292.
32. Anderson JM, Shive MS. 1997. Biodegradation and biocompatibility of PLA and
PLGA microspheres.
Advanced Drug Deliv Reviews
28: 5-24.
33. Alyautdin RN, Petrov VE, Langer K, Berthold A, Kharkevich DA, Kreuter J.
1997. Delivery of loperamide across the blood brain barrier with polysorbate-80
coated polybutylcyanoacrylate nanoparticles.
Pharmaceutical Research
14(3).
34. Kreuter J, Alyautdin RN, Kharkevich DA, Ivanov A. 1995. Passage of peptides
through the blood-brain barrier with colloidal polymer particles (nanoparti-
cles).
Brain Res
674: 171-4.
35. Bjustad KB, Redmond DE, Lampe KJ, Kern DS, Sladek JR, Mahoney MJ. 2008.
Biocompatibility of PEG-hydrogels in primate brain.
Cell Transplantation
17: 409-15.
36. Perry J, Chambers A, Spithof KF, Laperriere N. 2007. Gliadel wafers in the
treatment of malignant glioma: A systematic review.
Curr Oncol
. October 14(5):
189-194.
37. Bjustad KB, Lampe K, Kern DS, Mahoney M. 2010. Biocompatibility of
poly(ethylene glycol)-based hydrogels in the brain: An analysis of the glial
response across space and time.
J Biomed Mat Res A
Oct, Vol 96A (1).
38. Thornhoff JR, Lou DJ, Jordan PM, Zhao X, Wu P. 2008. Compatibility of human
fetal neural stem cells with hydrogel biomaterials in vitro.
Brain Res.
1187: 42-51.
39. Uibo R, Laidmae I, Sawyer ES, Flanagan LA, Penelope C, Winder JP, Janmey PA.
2009. Soft materials to treat central nervous system injuries: Evaluation of the suit-
ability of non-mammalian fibrin gels.
Biochim Biophys Acta
. May 1793(5): 924-30.
40. Babensee JH. Interaction of dendritic cells with biomaterials. 2008.
Demin
Immunol
20: 101-108.
Search WWH ::
Custom Search